• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

A preliminary cervical cancer screening cascade for eight provinces rural Chinese women: a descriptive analysis of cervical cancer screening cases in a 3-stage framework

摘要Background:Cascade analysis is an effective method to analyze the processing data of an event,such as a provided service or a series of examinations.This study aimed to develop a primary cervical cancer screening cascade in China to promote the quality of the screening process.Methods:We designed a cervical cancer screening cascade in China according to the program flow chart.It had three stages,each with two steps and one result.Data from 117,522 women aged 35 to 64 years in the Rural Cervical Cancer Surveillance Project from January 1,2014,to December 31,2014,were collected to analyze the main results of the cascade.The data and proportion are used to describe the follow-up of cervical cancer and pre-cancer detection rate.Results:In 2014,117,522 (80.94% of all cases reported by the Rural Cervical Cancer Surveillance Project) women aged 35 to 64 years had not received cervical cytology in the previous 3 years.The pre-cancer and cancer detection rates were 256.12/100,000 and 16.16/100,000,respectively.A total of 3031 cases failed to follow-up through the screening process,and 1189,1555,and 287 cases were lost at cervical cytology,colposcopy,and histopathological screening stages,respectively.The estimated cases of pre-cancer and cancer cases would have been 544 and 34,respectively,and the estimated detection rates of pre-cancer and cancer would have been 462.89/100,000 and 28.93/100,000,respectively.Conclusion:In order to increase the detection rate of cervical cancer,cervical cancer screening staff should focus on increasing the rate of follow-up of those who are positive for cervical cancer screening (ie,those with positive cytology results),especially for the 40 to 44 years age range.

更多
广告
作者单位 Department of Women's Health, National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing 100081, China [1] Center of Drug Reevaluation, National Medical Products Administration, Beijing 100044, China [2] Center for Project Supervision and Management, National Health Commission of China, Beijing 100044, China [3]
栏目名称
DOI 10.1097/CM9.0000000000000353
发布时间 2019-09-11
提交
  • 浏览16
  • 下载12
中华医学杂志(英文版)

中华医学杂志(英文版)

2019年132卷15期

1773-1779页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷